Used as a key intermediate in the synthesis of fluorinated pharmaceuticals, particularly in the development of selective kinase inhibitors. Its structure supports the construction of bioactive molecules with enhanced metabolic stability and binding affinity. Commonly employed in medicinal chemistry for optimizing lead compounds in drug discovery programs targeting inflammatory diseases and certain cancers. The bromo and amino functional groups allow for further derivatization via cross-coupling reactions or acylation, making it valuable in building complex drug-like molecules.